Two lung cancer drugs approved and one rejected for NHS Scotland

An immunotherapy and a targeted treatment have been recommended for use on the NHS

Failed cancer drug looks promising for scleroderma and other fibrotic conditions

Sixteen years ago, a research group at Mayo Medical School published results showing that

Chaotic talks show challenge of reaching opioid settlement

For months, the judge overseeing national litigation over the opioids crisis urged all sides

Compound offers prospects for preventing acute kidney failure

Russian researchers from the Moscow Institute of Physics and Technology, the Institute of Cell

Drug designed to treat metastatic pancreatic cancer may help extend life

A drug developed by researchers at the Renaissance School of Medicine at Stony Brook

Post opioid-overdose interventions emerge in US

Opioid-related deaths continue to take the lives of thousands in the U.S. each year,

Study shows hazardous patterns of prescription opioid misuse in the US

Among adults aged 18 years and older, 31 percent used prescription opioids only as

Research explores the use of new psychoactive substances by young people

A research study into New Psychoactive Substances (NPS)—formerly referred to as ‘legal highs’—provides new

New drug shows encouraging survival in pancreatic cancer

A clinical trial testing a new drug in pancreatic cancer had promising initial results,

Prescription drug misuse common in high schoolers

(HealthDay)—Misuse of prescription drugs is common among high school students, and those misusing prescription

Chemists teach old drug new tricks to target deadly staph bacteria

“Slaying superbugs, one antibiotic at a time,” is the motto of Bill Wuest’s chemistry

Drug trial shows efficacy in treating anemia in chronic kidney disease patients without dialysis

FibroGen, Inc. today announced publication of results from the Phase 3 trial of the

Nonprescription antibiotic use seems prevalent in the United States

Nonprescription antibiotic use appears to be prevalent in the United States, according to a

Eye drops, ointments sold at Walgreens recalled

(HealthDay)—A number of over-the-counter eye products sold at Walgreens have been recalled by manufacturer

Adding bevacizumab improves overall survival in NSCLC

(HealthDay)—The addition of bevacizumab to carboplatin/pemetrexed is associated with improved overall survival among patients

Topical cream shows promise in treatment of skin pigmentation disease, vitiligo

A nationwide phase II clinical trial, coordinated out of Tufts Medical Center in Boston,

Counterfeit medicine a ‘growing threat’: EU study

Counterfeit medicine is a “growing threat” in Europe, causing serious illness or even death

Naloxone access law in Pennsylvania falls short

A new study from researchers at the University of Illinois at Chicago finds that

Expert urges cautious approach to ketamine use

Physicians and patients are excited about ketamine, the latest drug to treat depression, but

Studying implications of policy and law for treatment of substance use disorders

People who suffer from substance use disorder need effective treatments, however, 90 percent of

Most preventive antibiotics prescribed by dentists are unnecessary

A new study conducted by researchers at the University of Illinois at Chicago and

Researchers finds new RX target for common STD

Research led by Ashok Aiyar, Ph.D., Associate Professor of Microbiology, Immunology and Parasitology at

Daratumumab cuts risk for progression in multiple myeloma

(HealthDay)—For patients with newly diagnosed multiple myeloma, the addition of daratumumab to lenalidomide and

FDA approves $2M medicine, most expensive ever

U.S. regulators have approved the most expensive medicine ever, for a rare disorder that

U.S. lawmakers say WHO opioid guidelines too lax

The World Health Organization’s pain care guidelines contain false claims about the safety of

Medication nonadherence common in patients with T2DM

(HealthDay)—Routine urine samples can be used to test for medication adherence in patients with

As more veterans die of opioid overdoses, study shows need to focus beyond prescriptions

A dramatic rise in opioid overdose deaths among American veterans in recent years has

Rising prescription drug costs continue to create tough choices for seniors

(HealthDay)—A solid minority of senior citizens still struggles to afford their prescription medications, a

Avelumab and axitinib approved for treatment of renal cell carcinoma

(HealthDay)—Avelumab (BAVENCIO) was approved this week for first-line treatment of advanced renal cell carcinoma

Americans’ prescription med use is declining

(HealthDay)—Bucking a longstanding upward trend, new data shows that the percentage of Americans taking